PeptidePedia The community reference

Chain of custody (revision 32)

Old revision·19:26, 30 Jan 2026·Chromatokid

This is an old revision of this page, as it stood at 19:26, 30 Jan 2026, saved by Chromatokid with the summary state the method the reporting service uses, since it is not the only one available. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Chain of custodySampling discipline
RecordsWho held the sample, when, and under what conditions
PurposeExcludes substitution, tampering and undocumented excursion
Pairs withBlind sampling
Analytical method infobox · conventions

A chain of custody is the documented sequence of individuals who held a sample between the moment it was drawn and the moment it was analysed, together with the conditions under which it was held and the transfers between them. Its purpose is to exclude substitution, tampering and undocumented storage excursions as explanations for a result.[1]

In the context of peptide testing, an unbroken chain of custody is uncommon. Most independent reports arise from material bought, shipped, stored for an unknown period and then submitted, with no documentation of any of it. This does not make the results worthless; it bounds what they can establish.[2]

Chain of custody is complementary to blind sampling. Blind sampling addresses selection — whether the sample was chosen to be favourable. Chain of custody addresses handling — whether the sample analysed is the sample drawn, unchanged.

What the record contains

[edit]

A chain-of-custody record identifies the sample uniquely, names each person who held it with the dates of transfer, and states the storage conditions maintained at each stage. Where temperature matters, a record without temperature is incomplete.[1]

For peptides, temperature and time are the conditions that matter most, because the degradation routes — deamidation, oxidation, aggregation — are all time- and temperature-dependent. A sample held at ambient temperature for three weeks before analysis may return a lower purity than the same material analysed on receipt, and without a record it is impossible to attribute the difference.[3][4]

This is the single most common confound in community testing. A result reported as characterising a supplier's material may be characterising the purchaser's storage, and the two are indistinguishable without a custody record. See Temperature excursion.

Why it is usually absent

[edit]

The ordinary sequence for a community-submitted report is: material is bought; it is shipped by a carrier under unknown conditions; it is received and stored by the purchaser for some period; a vial is selected; it is posted to a laboratory. No step in that sequence is documented in a way that would satisfy a custody requirement.[2]

The consequences run in both directions and are not symmetric in the way people usually assume. Degradation in transit or storage produces a result worse than the material as shipped, so an unfavourable result from an uncontrolled chain is weak evidence against a supplier. A favourable result is less affected, since degradation does not improve purity — but it says nothing about whether that vial was representative.

The practical upshot is that uncontrolled-chain results are more informative when favourable than when unfavourable, which is the reverse of how they are usually read.

Approximations available in practice

[edit]

Full custody documentation is not achievable for community testing, but several partial measures narrow the gap and appear in submissions to this wiki.[2]

MeasureWhat it excludes
Analysis on receipt, unopenedPurchaser storage
Temperature indicator in the shipmentUndocumented transit excursion
Sending direct from supplier to laboratoryPurchaser handling entirely
Photographing the sealed vial before dispatchSubstitution after receipt
Retaining a second unit unopenedAllows re-analysis if disputed

Direct supplier-to-laboratory shipment is the strongest of these, and it also converts an unblinded submission into something closer to blind sampling if the supplier is not told the destination is a laboratory. Whether that is achievable depends on the transaction and is not always possible.

None of this makes an uncontrolled result useless. It makes explicit what the result is evidence for, which is the aim.[1]

See also

References

  1. ^ a b c ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories, clause 7.4 (handling of test items).
  2. ^ a b c PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see Project:Sourcing guidelines).
  3. ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
  4. ^ International Council for Harmonisation, Q1A(R2): Stability Testing of New Drug Substances and Products (2003).